Frontiers in Immunology | Cancer Immunity and Immunotherapy

General Commentary

Accepted on 20 Feb 2025

Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysis：A commentary

in Cancer Immunity and Immunotherapy

Peiqin Zhan
Wujie Chen
Junhao Chen
Junxian Zhao
Mingxia Ding
Shi Fu
Jiansong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1506205

Original Research

Accepted on 20 Feb 2025

Association of Type 2 Diabetes, Hypertension, and Hyperlipidemia with Immune-Related Adverse Events in Patients Undergoing Immune Checkpoint Inhibitors Therapy

in Cancer Immunity and Immunotherapy

Ruidan Li
Xiaoli Mu
Zheran Liu
Rendong Huang
Xingchen Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1472197

Original Research

Published on 20 Feb 2025

Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing

in Cancer Immunity and Immunotherapy

Xiaolan Mu
Lili Pan
Xicheng Wang
Changcheng Liu
Yu Li
Yongchao Cai
Zhiying He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1529569

131 views

Original Research

Published on 20 Feb 2025

Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA

in Cancer Immunity and Immunotherapy

Long Qian
Luman Wang
Hao Chen
Song Wang
Yinfen Hou
Li Xu
Yabin Xia
Maoqi Xu
Xiaoxu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1511247

126 views

Original Research

Published on 20 Feb 2025

Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide

in Cancer Immunity and Immunotherapy

Qi Wang
Zhao-Ting Ren
Hui-Feng Wu
Hao-Chen Gu
Xia-Wei Li
Zhuang-Li Tang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530919

Original Research

Published on 20 Feb 2025

Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death

in Cancer Immunity and Immunotherapy

Yongbin Ye
Ning Liu
Yunxin Zeng
Ziwen Guo
Xiaobo Wang
Xiaojun Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1521939

115 views

Original Research

Published on 20 Feb 2025

Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Liu-Xia Yuan
Zhi-Qiang Yue
Qin-Rong Ma
Peng Zhang
Feng Xiao
Lin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528853

Original Research

Accepted on 19 Feb 2025

New insights into Markers for Distinguishing Neuroendocrine Prostate Cancer: Evidence from Single-cell Analysis

in Cancer Immunity and Immunotherapy

Hailang Luo
Chen Jin
Boyang Li
Meng Zhang
Zongyao Hao
Qintao Ge
Chaozhao Liang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551815

Original Research

Accepted on 19 Feb 2025

Therapeutic Potential of Isochlorogenic Acid A from Taraxacum officinale in Improving Immune Response and Enhancing the Efficacy of PD-1/PD-L1 blockade in Triple-Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Tangyi Wang
Jingwei Sun
Li Wang
Yuxin Lin
Zhijing Wu
Qiangqiang Jia
Shoude Zhang
Juan An
Xueman Ma
Qiong Wu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1529710

Original Research

Accepted on 19 Feb 2025

Effect of Metachronous Primary and Secondary Solid Cancers in Patients with Multiple Myeloma: A Retrospective Study from a Single-Center

in Cancer Immunity and Immunotherapy

Yunfei Ji
Hujun Li
Huanxin Zhang
Hai Cheng
Ying Wang
Kailin Xu
Zhenyu Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516471

Review

Accepted on 19 Feb 2025

The Role of Immune Regulation in HBV Infection and Hepatocellular Carcinogenesis

in Cancer Immunity and Immunotherapy

海龙郑
BingChen Xu
Aekkachai Tuekprakhon Tuekprakhon
Yiyu Fan
Zania Stamataki
Fei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1506526

Original Research

Accepted on 19 Feb 2025

TMED9: A Potential Therapeutic Target and Prognostic Marker in Glioma and Its Implications Across Pan-Cancer Contexts

in Cancer Immunity and Immunotherapy

Benyong Mi
Chaolin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558881

Review

Published on 19 Feb 2025

Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

in Cancer Immunity and Immunotherapy

Zishan Yang
Bingjun Ha
Qinhan Wu
Feng Ren
Zhinan Yin
Hongru Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544532

217 views

Original Research

Published on 19 Feb 2025

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer

in Cancer Immunity and Immunotherapy

Rui Huang
Yi Li
Kaige Lin
Luming Zheng
Xiaoru Zhu
Leqiu Huang
Yunhan Ma

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512859

133 views

Original Research

Accepted on 18 Feb 2025

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

in Cancer Immunity and Immunotherapy

Astrid Musnier
Yannick Corde
Adrien Verdier
Mélanie Cortes
Christophe Dumet
Jean-René Pallandre
Adeline Bouard
Abdelraouf Keskes
Zakaria Omahdi
Vincent Puard

Frontiers in Immunology

doi 10.3389/fimmu.2025.1499810

Original Research

Accepted on 18 Feb 2025

Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals the Oncogenic Role of ANXA5 in Gastric Cancer and Its Association with Drug Resistance

in Cancer Immunity and Immunotherapy

Denggang Chen
Peng Zhang
Li Gong
Hailang Wei
Chen Bai
Tingting Zhang
Guanghui Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562395

Navigation group

Articles

Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysis：A commentary

Association of Type 2 Diabetes, Hypertension, and Hyperlipidemia with Immune-Related Adverse Events in Patients Undergoing Immune Checkpoint Inhibitors Therapy

Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing

Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA

Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide

Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death

Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

New insights into Markers for Distinguishing Neuroendocrine Prostate Cancer: Evidence from Single-cell Analysis

Therapeutic Potential of Isochlorogenic Acid A from Taraxacum officinale in Improving Immune Response and Enhancing the Efficacy of PD-1/PD-L1 blockade in Triple-Negative Breast Cancer

Effect of Metachronous Primary and Secondary Solid Cancers in Patients with Multiple Myeloma: A Retrospective Study from a Single-Center

The Role of Immune Regulation in HBV Infection and Hepatocellular Carcinogenesis

TMED9: A Potential Therapeutic Target and Prognostic Marker in Glioma and Its Implications Across Pan-Cancer Contexts

Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals the Oncogenic Role of ANXA5 in Gastric Cancer and Its Association with Drug Resistance